Cbio A/S is a biopharmaceutical company developing next generation T-cell therapies against solid tumors. We are soon to enter our First-in-Human clinical study at Karolinska Hospital in Sweden with our proprietary T-cell product, novoleucel, where the T-cell are armed against oxidative stress.
We are located in Copenhagen, Denmark in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Transformervej 8, Søborg,capital Region 2860,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cbio.dk
- Keywords
- Herlev.
- HQ
- Søborg, Capital Region
Cbio A/s Questions
Cbio A/S's website is http://www.cbio.dk
Cbio A/S's LinkedIn profile is https://dk.linkedin.com/company/cbio-a-s
Cbio A/S has
11 employees.
View email and phone details for 11
employees at Cbio A/S.
Cbio A/S's industry is
Biotechnology Research
Cbio A/S's top competitors are
Alk,
Unseen Bio,
Gubra,
Ascendis Pharma,
Cell To Cure Aps,
Ccit-Dk - National Center For Cancer Immune Therapy Of Denmark,
Nordic Bioscience,
Cbio,
Evaxion A/s,
Minerva Imaging.
Cbio A/S's categories are Biotechnology Research
Cbio A/S's founding year is 2019
